299 related articles for article (PubMed ID: 29938218)
21.
Huang Y; Tian C; Li Q; Xu Q
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022963
[TBL] [Abstract][Full Text] [Related]
22. 5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme.
Ciccarone F; Valentini E; Zampieri M; Caiafa P
Oncotarget; 2015 Sep; 6(27):24333-47. PubMed ID: 26136340
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis.
Wu MZ; Chen SF; Nieh S; Benner C; Ger LP; Jan CI; Ma L; Chen CH; Hishida T; Chang HT; Lin YS; Montserrat N; Gascon P; Sancho-Martinez I; Izpisua Belmonte JC
Cancer Res; 2015 Sep; 75(18):3912-24. PubMed ID: 26294212
[TBL] [Abstract][Full Text] [Related]
24. Suppression of TET1-dependent DNA demethylation is essential for KRAS-mediated transformation.
Wu BK; Brenner C
Cell Rep; 2014 Dec; 9(5):1827-1840. PubMed ID: 25466250
[TBL] [Abstract][Full Text] [Related]
25. Hydroxyurea promotes TET1 expression and induces apoptosis in osteosarcoma cells.
Teng S; Ma C; Yu Y; Yi C
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988069
[TBL] [Abstract][Full Text] [Related]
26.
Greer CB; Wright J; Weiss JD; Lazarenko RM; Moran SP; Zhu J; Chronister KS; Jin AY; Kennedy AJ; Sweatt JD; Kaas GA
J Neurosci; 2021 Jan; 41(4):578-593. PubMed ID: 33262245
[TBL] [Abstract][Full Text] [Related]
27. TET1 Deficiency Impairs Morphogen-free Differentiation of Human Embryonic Stem Cells to Neuroectoderm.
Li H; Hu Z; Jiang H; Pu J; Selli I; Qiu J; Zhang B; Feng J
Sci Rep; 2020 Jun; 10(1):10343. PubMed ID: 32587369
[TBL] [Abstract][Full Text] [Related]
28. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.
Shirai K; Nagae G; Seki M; Kudo Y; Kamio A; Hayashi A; Okabe A; Ota S; Tsutsumi S; Fujita T; Yamamoto S; Nakaki R; Kanki Y; Osawa T; Midorikawa Y; Tateishi K; Ichinose M; Aburatani H
Cancer Sci; 2021 Jul; 112(7):2855-2869. PubMed ID: 33970549
[TBL] [Abstract][Full Text] [Related]
29. Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer.
Bao B; Teslow EA; Mitrea C; Boerner JL; Dyson G; Bollig-Fischer A
Mol Cancer Res; 2020 Dec; 18(12):1803-1814. PubMed ID: 32913111
[TBL] [Abstract][Full Text] [Related]
30. ERK/c-Jun Recruits Tet1 to Induce Zta Expression and Epstein-Barr Virus Reactivation through DNA Demethylation.
Zhang W; Han D; Wan P; Pan P; Cao Y; Liu Y; Wu K; Wu J
Sci Rep; 2016 Oct; 6():34543. PubMed ID: 27708396
[TBL] [Abstract][Full Text] [Related]
31. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK
PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
[TBL] [Abstract][Full Text] [Related]
32. TET1 exerts its tumour suppressor function by regulating autophagy in glioma cells.
Fu R; Ding Y; Luo J; Yu L; Li CL; Li DS; Guo SW
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28341638
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.
Wang K; Chen Z; Shi J; Feng Y; Yu M; Sun Y; Zhuang Q; Liang B; Luo G; Xu X; Fan M
Prostate; 2020 Sep; 80(12):977-985. PubMed ID: 32542727
[TBL] [Abstract][Full Text] [Related]
34. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
35. Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications.
Banerjee A; Bardhan A; Sarkar P; Datta C; Pal DK; Saha A; Ghosh A
Pathol Res Pract; 2024 Jan; 253():154970. PubMed ID: 38056136
[TBL] [Abstract][Full Text] [Related]
36. TET1 is controlled by pluripotency-associated factors in ESCs and downmodulated by PRC2 in differentiated cells and tissues.
Neri F; Incarnato D; Krepelova A; Dettori D; Rapelli S; Maldotti M; Parlato C; Anselmi F; Galvagni F; Oliviero S
Nucleic Acids Res; 2015 Aug; 43(14):6814-26. PubMed ID: 25925565
[TBL] [Abstract][Full Text] [Related]
37. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
38. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
Kai M; Niinuma T; Kitajima H; Yamamoto E; Harada T; Aoki H; Maruyama R; Toyota M; Sasaki Y; Sugai T; Tokino T; Nakase H; Suzuki H
PLoS One; 2016; 11(12):e0168281. PubMed ID: 27977763
[TBL] [Abstract][Full Text] [Related]
39. TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target.
Chen LY; Huang RL; Chan MW; Yan PS; Huang TS; Wu RC; Suryo Rahmanto Y; Su PH; Weng YC; Chou JL; Chao TK; Wang YC; Shih IM; Lai HC
J Pathol; 2019 Jul; 248(3):363-376. PubMed ID: 30883733
[TBL] [Abstract][Full Text] [Related]
40. Hypermethylation of TET1 promoter is a new diagnosic marker for breast cancer metastasis.
Sang Y; Cheng C; Tang XF; Zhang MF; Lv XB
Asian Pac J Cancer Prev; 2015; 16(3):1197-200. PubMed ID: 25735355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
